department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

when

Latest
Archive

by source

All Sources
Sources Page

by activity

Most Active
Biggest Pipelines
Recently Active

hiring

Companies Hiring Now
Big Pharma Roles
All Companies →

Drugs & Pipeline

intelligence

Drugs
Patent Cliff

research

Publications
Topics

window

Next 90 Days
All (incl. Past)

by type

PDUFAs
Approvals
Earnings
Readouts

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Calendar
Drugs
Companies
News

Hubs

Topics
Jobs
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
cal
search

Capecitabine · pharmadog

pharmadog
drugs
Capecitabine

drug

patient view →

capecitabine

Marketedupdated 2mo ago

by Armas Pharmaceuticals Inc

Approved

community read0 votes

indications

investigational

Colorectal Cancer

all catalysts(3)

phase 2 completion · 2

phase 3 completion · 1

News(0)

no news has mentioned this drug yet

brand

Capecitabine

generic

capecitabine

indication

Colon Cancer

phase

marketed

phase 2 completion

Japanese Governmental Office — capecitabine (Phase II Trial Completion)

phase 2 completion

Cancer Institute and Hospital Chinese Academy of Medical Sciences — capecitabine (Phase II Trial Completion)

phase 3 completion

Sun Yat-sen Memorial Hospital — capecitabine (Phase III Trial Completion)

Data sources

ClinicalTrials.gov

last refreshed 53m ago

Found something off?

🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

🐶 often sniffed alongside

top 7

tagApproval72 co-mentions · 36 sources
tagSmall Molecule36 co-mentions · 36 sources
tagOncology7 co-mentions · 3 sources
tagColorectal Cancer2 co-mentions · 2 sources
companyJapanese Governmental Office1 co-mentions · 1 sources
companySun Yat-sen Memorial Hospital1 co-mentions · 1 sources
companyCancer Institute and Hospital Chinese Academy of Medical Sciences1 co-mentions · 1 sources

Trials studying capecitabine

phase3Efficacy and Safety of Utidelone Capsule and Utidelone Injection in Patients With HER-2 Negative Advanced Breast Cancernot yet recruitingn=308
phase2Phase Ib/IIa Open-label Study, to Evaluate Safety, Tolerability, and Antitumor Activity of HCB101 in Combination With Multiple Agents in Subjects With Advanced Gastric or Gastro-esophageal (GEJ) Adenocarcinomanot yet recruitingn=40
phase2Pan Tumor Rollover Studyrecruitingn=1,500
phase1Capecitabine In Combination With Cemiplimab In Patient With Metastatic Breast Cancercompletedn=13
phase2A Clinical Study of TQB2930 Injection and Chemotherapy With or Without Bevacizumab in the Treatment of Advanced Colorectal Cancernot yet recruitingn=71
phase2Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)recruitingn=454
phase3A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treatment for HER2-positive Gastric Cancerrecruitingn=840
phase2A Study of Novel Agents or Combinations as Perioperative Treatment in Participants With Locally Advanced Resectable Gastroesophageal Adenocarcinomarecruitingn=100

more trials →